Aspirin and clonidine in non-cardiac surgery: Acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial

BMJ Open

Volumn 4, Issue 2, 2014, Pages

  Garg, Amit X ^a   Kurz, Andrea ^b   Sessler, Daniel I ^b   Cuerden, Meaghan ^c   Robinson, Andrea ^d   Mrkobrada, Marko ^a   Parikh, Chirag ^e   Mizera, Richard ^d   Jones, Philip M ^a   Tiboni, Maria ^d   Rodriguez, Raul Gonzalez ^f   Popova, Ekaterina ^f   Gomez, Maria Fernanda Rojas ^g   Meyhoff, Christian S ^h   Vanhelder, Tomas ^d   Chan, Matthew T V ⁱ   Torres, David ^j   Parlow, Joel ^k   De Nadal Clanchet, Miriam ^l   Amir, Mohammed ^m   Bidgoli, Seyed Javad ⁿ   Pasin, Laura ^o   Martinsen, Kristian ^p   Malaga, German ^q   Myles, Paul ^r   Acedillo, Rey ^a   Roshanov, Pavel ^a   Walsh, Michael ^d   Dresser, George ^a   Kumar, Priya ^s   Fleischmann, Edith ^t   Villar, Juan Carlos ^u   Painter, Tom ^v   Biccard, Bruce ^w   Bergese, Sergio ^x   Srinathan, Sadeesh ^y   Cata, Juan P ^z   Chan, Vincent ^aa   Mehra, Bhupendra ^ab   Leslie, Kate ^ac   Whitlock, Richard ^d   Devereaux, P J ^d   more..

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WATERLOO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e YALE UNIVERSITY   (United States)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g Research Institute of the Fundacion Oftalmologica de Santander FOSCAL   (Colombia)

^h GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j CLÍNICA SANTA MARÍA   (Chile)

^k KINGSTON GENERAL HOSPITAL   (Canada)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

ⁿ BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^o SAN RAFFAELE HOSPITAL   (Italy)

^p LILLEBAELT HOSPITAL   (Denmark)

^q HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^r MONASH UNIVERSITY   (Australia)

^s UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF VIENNA   (Austria)

^u FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

^v ROYAL ADELAIDE HOSPITAL   (Australia)

^w UNIVERSITY OF KWAZULU NATAL   (South Africa)

^x THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^y UNIVERSITY OF MANITOBA   (Canada)

^z UNIVERSITY OF TEXAS   (United States)

^aa UNIVERSITY OF TORONTO   (Canada)

^ab MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

^ac ROYAL MELBOURNE HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLONIDINE; CREATININE; PLACEBO; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CREATININE BLOOD LEVEL; FOLLOW UP; HUMAN; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NON CARDIAC SURGERY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SURGICAL TECHNIQUE; URINE VOLUME; ACUTE KIDNEY INJURY; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; GLOMERULUS FILTRATION RATE; METHODOLOGY; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE;

ACUTE KIDNEY INJURY; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CLONIDINE; CREATININE; GLOMERULAR FILTRATION RATE; HUMANS; INTRAOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RENAL INSUFFICIENCY, CHRONIC; RESEARCH DESIGN;

EID: 84896853791     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-004886     Document Type: Article

References (36)

1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008;372:139-44.
2. Abelha FJ, Botelho M, Fernandes V, et al. Determinants of postoperative acute kidney injury. Crit Care 2009;13:R79.
3. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365- 70.
4. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008;73:538-46. (Pubitemid 351264114)
5. Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;53:961-73.
6. Landoni G, Bove T, Szekely A, et al. Reducing mortality in acute kidney injury patients: systematic review and international web-based survey. J Cardiothorac Vasc Anesth 2013;27:1384-98.
7. Gerrah R, Izhar U. Beneficial effect of aspirin on renal function post-cardiopulmonary bypass. Asian Cardiovasc Thorac Ann 2003;11:304-8. (Pubitemid 38239848)
8. Gerrah R, Ehrlich S, Tshori S, et al. Beneficial effect of aspirin on renal function in patients with renal insufficiency postcardiac surgery. J Cardiovasc Surg (Torino) 2004;45:545-50. (Pubitemid 41490610)
9. Mangano DT. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-17. (Pubitemid 35215321)
10. Serhan CN, Arita M, Hong S, et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004;39:1125-32. (Pubitemid 40129055)
11. Serhan CN, Gotlinger K, Hong S, et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 2004;73:155-72. (Pubitemid 38757795)
12. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61. (Pubitemid 351595216)
13. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007;25:101-37.
14. Duffield JS, Hong S, Vaidya VS, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006;177:5902-11. (Pubitemid 44628803)
15. Cao L, Young N, Liu H, et al. Preoperative aspirin use and outcomes in cardiac surgery patients. Ann Surg 2012;255:399-404.
16. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006;1:19-32.
17. Devereaux PJ. http://clinicaltrials.gov/ct2/show/NCT01082874? term=POISE-2&rank=1. (last accessed 16 Jan 2014), 2014.
18. Doutremepuich C, Aguejouf O, Desplat V, et al. Aspirin discontinuation syndromes: clinical implications of basic research studies. Am J Cardiovasc Drugs 2013;13:377-84.
19. Kulka PJ, Tryba M, Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 1996;24:947-52. (Pubitemid 26189934)
20. Myles PS, Hunt JO, Holdgaard HO, et al. Clonidine and cardiac surgery: haemodynamic and metabolic effects, myocardial ischaemia and recovery. Anaesth Intensive Care 1999;27:137-47. (Pubitemid 29164104)
21. Billings FT, Chen SW, Kim M, et al. Alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol 2008;295:F741-8.
22. Eknoyan G, Dobyan DC, Senekjian HO, et al. Protective effect of oral clonidine in the prophylaxis and therapy of mercuric chloride - induced acute renal failure in the rat. J Lab Clin Med 1983;102:699-713. (Pubitemid 14228262)
23. Solez K, Racusen LC, Whelton A. Glomerular epithelial cell changes in early postischemic acute renal failure in rabbits and man. Am J Pathol 1981;103:163-73. (Pubitemid 11112971)
24. Ideura T, Solez K, Heptinstall RH. The effect of clonidine on tubular obstruction in postischemic acute renal failure in the rabbit demonstrated by microradiography and microdissection. Am J Pathol 1980;98:123-50. (Pubitemid 10176938)
25. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
26. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int 2012;2:1-138.
27. Austin PC. Absolute risk reductions, relative risks, relative risk reductions, and numbers needed to treat can be obtained from a logistic regression model. J Clin Epidemiol 2010;63:2-6.
28. Kahan BC, Morris TP. Adjusting for multiple prognostic factors in the analysis of randomised trials. BMC Med Res Methodol 2013;13:99.
29. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-12. (Pubitemid 28502420)
30. Bender R. Calculating confidence intervals for the number needed to treat. Control Clin Trials 2001;22:102-10. (Pubitemid 32289446)
31. Brown JR, Kramer RS, Coca SG, et al. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 2010;90:1142-8.
32. Juhlin T, Jonsson BA, Hoglund P. Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg. Eur J Heart Fail 2008;10:892-8.
33. Acedillo RR, Shah M, Devereaux PJ, et al . The risk of perioperative bleeding in patients with chronic kidney disease: a systematic review and meta-analysis. Ann Surg 2013;258:901-13.
34. Vellinga S, Verbrugghe W, De PR, et al. Identification of modifiable risk factors for acute kidney injury after cardiac surgery. Neth J Med 2012;70:450-4.
35. Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013;158:825-30.
36. Gaspari F, Ruggenenti P, Porrini E, et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013;84:164-73.